PAR 0.00% 27.5¢ paradigm biopharmaceuticals limited..

We just submitted an IND - So now what?, page-134

  1. 1,241 Posts.
    lightbulb Created with Sketch. 283
    I disagree. This is a quick and vital update given in good time. Nothing more required at this stage. I expect it is a stall from FDA because of the scale of the IND. If the company continues to respond quickly to anything the FDA asks then it should provide more confidence to the FDA that the company knows its stuff. I'm calm, composed and will happily see the SP rise after 30 June (and right up until 19 September).
    Last edited by Violin1: 26/04/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.